Norbert Tennagels

USPTO Granted Patents = 22 (Patent Applications = 9)

EPO Patents = 16 (Patent Applications = 11)

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 38(Granted Patents)

Location History:

Siegburg, DE (2008 - 2013)
Frankfurt-am-Main, DE (2006 - 2022)

Company Filing History:

9 out of 1,829

Sanofi-a Ventis Deutschland Gmbh

Hanmi Pharm. Co., Ltd.

patents

5. 1 out of 1

Sanfoi-aventis Deutschland Gmbh

patent

where one patent can have more than one assignee

Years Active: 2006-2022

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11396534 - Insulin analogs with reduced affinity to insulin receptor and use thereof (2022-07-26),

2. 11090364 - Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein (2021-08-17),

3. 9644017 - Insulin derivatives having an extremely delayed time-action profile (2017-05-09),

4. 8933024 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases (2015-01-13),

5. 8921404 - Azole derivatives in the form of lipase and phospholipase inhibitors (2014-12-30),

6. 8735437 - Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors (2014-05-27),

7. 8633156 - Insulin derivatives having an extremely delayed time-action profile (2014-01-21),

8. 8357698 - Diacyl indazole derivatives as lipase and phospholipase inhibitors (2013-01-22),

9. 8148395 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases (2012-04-03),

10. 8008331 - Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors (2011-08-30),

11. 7897625 - Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases (2011-03-01),

12. 7897616 - Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases (2011-03-01),

13. 7846943 - Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors (2010-12-07),

14. 7803571 - Method for identifying IRS inhibitors or agonists (2010-09-28),

15. 7772268 - Diacyl indazole derivatives as lipase and phospholipase inhibitors (2010-08-10),

Title: Norbert Tennagels: Pioneering Inventor from Frankfurt am Main

Introduction: Norbert Tennagels is a renowned inventor hailing from Frankfurt am Main, Germany, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Tennagels holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Norbert Tennagels has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries such as automotive, aerospace, and electronics.

Collaborations: Tennagels has collaborated with top universities and multinational corporations to bring his inventions to market, demonstrating his ability to bridge the gap between academia and industry for real-world impact.

Conclusion: Norbert Tennagels' passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the landscape of technology and sustainability for years to come.

This text is generated by artificial intelligence and may not be accurate.